Select A Team:

About Us

Sample Event

Join us on sample date

About 5K Walk/Run Program

Held annually in thirteen cities across the country — Atlanta, Boston, Charlotte, Chicago, Dallas, Los Angeles, New York City, Philadelphia, San Francisco, Tri-State (Norwalk, CT), Twin Cities, Washington D.C., and South Florida — this family friendly 5K walk/run raises both awareness and funds for multiple myeloma. Since its inception in 2001 in Chicago, the MMRF Team for Cures 5K Walk/Run Program has raised more than $28.5 million to support the Multiple Myeloma Research Foundation’s urgent work. Come walk, run or stroll with myeloma families, friends, patients and health professionals at this inspiring event which celebrates the progress we are making and offers a way for you to support the critical work the MMRF is doing to extend the lives of patients and find a cure.

About the MMRF

The MMRF was founded in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy was diagnosed with multiple myeloma, an incurable blood cancer. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. Nearly 90% of total budget goes directly to research and related programming. The MMRF has been awarded Charity Navigator’s coveted four star rating for 12 consecutive years, the highest designation for outstanding fiscal responsibility and exceptional efficiency. The MMRF has facilitated unprecedented accomplishments including helping to bring ten new drugs to market that are now standard therapies for patients with multiple myeloma and being used or explored as treatments for other cancers.

Our accomplishments include:

Establishing a multi-center tissue bank with more than 4,000 samples.

Spearheading an initiative to map the multiple myeloma genome with world-class leaders in genomics.

Launching the groundbreaking CoMMpass? Study to collect and analyze multiple tissue samples from 1,000 patients over a multi-year course, so that patients will eventually be matched with the right clinical studies and treatments.

Building the CoMMunity Gateway, a platform to connect patients sharing sub-types of myeloma with each other and experts.